The Mountain Climbers' Problem

1993 ◽  
Vol 117 (1) ◽  
pp. 89 ◽  
Author(s):  
Tamas Keleti
Keyword(s):  
2017 ◽  
Vol 71 (1) ◽  
pp. 12-20 ◽  
Author(s):  
Hamid Arazi ◽  
Tahmineh Saedi ◽  
Mani Izadi

The Race ◽  
2021 ◽  
pp. 88-89
Author(s):  
Eliyahu M. Goldratt ◽  
Robert E. Fox
Keyword(s):  

2019 ◽  
Vol 119 (11) ◽  
pp. 6595-6612 ◽  
Author(s):  
Jessica G. Freeze ◽  
H. Ray Kelly ◽  
Victor S. Batista

Author(s):  
James G. Clawson ◽  
Gerry Yemen

Suitable for undergraduate, graduate, and executive education programs, this version of the K2 story provides the full version of the story based on sequential dates. Written as a replacement for the much-used Greenland Case (UVA-OB-0581) this undisguised case can be taught in a similar manner. Chris Warner led a team of experienced mountain climbers on an expedition to reach the summit of K2—the second highest in the world. After failing to succeed on their first two attempts, Warner and his team brought together other teams representing eight different countries hoping to work together for success. Their story is an account full of examples where a leadership point of view was taken or not taken. The successes and failures of the expedition's approach is bursting with real world examples and offers an exciting framework to house theoretical concepts about team building and leadership. A video supplement is available to enhance student learning.


2019 ◽  
Vol 19 (5) ◽  
pp. 404-411 ◽  
Author(s):  
Marieke Cornelia Johanna Dekker ◽  
Mark H Wilson ◽  
William Patrick Howlett

Mountain climbers may develop specific illnesses that largely depend on the altitude reached and the rate of ascent. The popularity of travel to high altitude destinations, extreme tourist activities and mountain climbing means that neurologists in low-altitude countries are increasingly likely to encounter neurological problems and disorders in people exposed to high altitude. Additionally, they may have to advise patients with pre-existing neurological conditions on the risks of ascent to altitude. This article focuses on neurological-related high-altitude illnesses: acute mountain sickness and high-altitude cerebral oedema, as well as high-altitude retinopathy and other neurological disorders. This overview combines current understood pathogenesis with the experience of managing altitude-related illness at the foot of Mount Kilimanjaro in northern Tanzania, the tallest free-standing mountain in the world.


Cephalalgia ◽  
2005 ◽  
Vol 25 (12) ◽  
pp. 1110-1116 ◽  
Author(s):  
M Serrano-Dueñas

Altitude headache (AH) is the most common symptom of high altitude exposure. This prospective cross-sectional and analytical study, conducted in the Ecuadorian Andes, aimed to explore AH symptomatology, taking into account subjects' views. Thirty mountain climbers took part in the Questionnaire Elaboration. The symptoms were grouped into three categories: (A) pain dimension (PD) — intensity, location, quality, outset form, evolution, exacerbating and relieving elements; (B) concurrent symptom dimension (CSD); and (C) feeling/mood dimension (FMD). Ninety-eight mountain climbers comprised the sample for Field Research. Three evaluations were carried out: 4700-5000 m, n = 1, and 5700-5800 m, n = 2. Pearson's correlation coefficient was used to assess internal consistency. Scores between 0.7 and 1 were considered as significant to assess the strength of association between the PD and its different items and CSD and FMD. The following clinical features were found: holocranial 65.6%; pulsatile-burst type quality 75.3%; oscillating evolution 36.7%; increasing with exercise 49.5%; relieved by rest 41.8%; concurrent symptoms referred to, anorexia 26.8%, irritability 26.5%, and finally pessimism and anxiety feelings 33.2 and 29.5%, respectively. We believe that elements provided by us must lead to a new official AH diagnosis criterion.


Sign in / Sign up

Export Citation Format

Share Document